MODULE 7: Buprenorphine and Methadone

Home
»
DEA Training Bundle
»
Product Details

You must select a location to proceed.

Yes

There was a problem adding this course to your account. Please try again in a few minutes. If the problem persists, you can contact our support department at (877) 880-1335.

Adding Registration, Please wait...

You must be logged in to perform this action.

Cancel

MODULE 7: Buprenorphine and Methadone

Part of the 8-Hour DEA Training Bundle: Clinical Approaches to Pain Management and Substance Use Disorders

Credit(s):

1.2 Contact Hour(s) of CE; 1 of which may be applied towards Pharmacology

Program Number:

25117586

Original Program Date:

December 4, 2025

Duration:

1 hour 1 minute

Access:

Available until May 31, 2027

Special Offer

Click here to see Special Offer(s)!

Facebook

E-Mail

Description
Sessions
Credits
Faculty
Materials
Reviews
Dates and Locations

(181)

Read Reviews

Category: DEA Training Bundle, Cert Exam Domain - Assessment, Cert Exam Domain - Evaluation ... (show more)

Category: DEA Training Bundle, Cert Exam Domain - Assessment, Cert Exam Domain - Evaluation, Cert Exam Domain - Planning, Controlled Substances, Courses that Meet DEA Requirements, Pharmacology, Psych/ Mental Health, Recent Additions, Substance Use Disorder (show less)

Subcategory: Addiction, Assessment, Chronic Pain ...(show more)

Subcategory: Addiction, Assessment, Chronic Pain, Controlled Substances, Neuropathic Pain, Opioids, Pain Management, Patient-Centered, Risk Management, Screening
(show less)

Activity Duration

Content Expires:

May 31, 2027 (11:55 p.m. CT)
CE for this activity will not be available after this date.

This activity includes closed captioning.

Overview

This module explains the pharmacology, safety considerations, and clinical application of buprenorphine and methadone for pain and opioid use disorder. It includes dosing principles, initiation strategies (including micro-induction), regulatory frameworks, and best practices for managing patients on MOUD across settings. The module emphasizes harm reduction, patient-centered care, and reducing barriers to medication access.

Objectives

Review the pharmacology, formulations, and uses of medications for opioid use disorder including buprenorphine, methadone, and naltrexone.
Discuss methods of initiating buprenorphine and how to employ a shared decision-making approach.
Understand the use of buprenorphine for pain management.
Review basic principles of harm reduction.

Speaker
Beth Williams, MSN, AGNP, MPH, CARN-AP

Disclosure
This program was planned in accordance with AANP CE Standards and Policies.

The speaker has the following disclosures:

I have nothing to disclose.

All Planners involved in this activity have no relevant financial relationships to disclose.

Disclaimer
Individuals who have contributed to the CE Center were carefully selected for their knowledge and experience in the subject area under review. This presentation is informational only and may contain opinions of the authors from their personal experience that do not necessarily express the opinions of the American Association of Nurse Practitioners (AANP). The activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. Clinical practice is a constantly changing process and new information becomes available every day. Neither AANP nor the contributing individuals can warrant that the material will continue to be accurate, nor do they warrant that the material is completely free of errors upon publication. Attendees and participants should appraise the information presented critically and are encouraged to consult appropriate resources for any product or device mentioned in this program.

CE Credit Instructions

Read this activity description, including objectives and disclosures.
Complete the educational content:
- Video Presentations: Click the Play button to watch the activity presentation. Full participation credit for the activity will be received once the entire video has been watched.
- Click on the Additional Resources button to review all additional materials provided (handouts, post-test reviews, any other downloadable resources).
After completing all content, click on the blue Next Steps button:
- Submit the post-test. (No passing score required.)
- Submit the activity evaluation.
- Click on the Get Certificate button.
  - A copy of your certificate of completion will display on the screen for you to print or save. A copy of the certificate will also be emailed to you.
  - A copy of the certificate and a record of your CE/Rx earned will be automatically added to your AANP CE Tracker.

Additional Information
For questions or more information concerning this online CE activity, please visit the AANP Help Center to find answers to frequently asked questions and request assistance.

1.2 Contact Hour(s) of CE,
1 of which may be applied towards Pharmacology